Masashi Mise

458 total citations
9 papers, 372 citations indexed

About

Masashi Mise is a scholar working on Pharmacology, Oncology and Biochemistry. According to data from OpenAlex, Masashi Mise has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Oncology and 3 papers in Biochemistry. Recurrent topics in Masashi Mise's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Masashi Mise is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Masashi Mise collaborates with scholars based in Japan and United States. Masashi Mise's co-authors include Takanori Hashizume, Setsuko Komuro, Yoshiaki Terauchi, Toshihiko Fujii, Toru Usui, Masashi Yabuki, Tetsuya Kamataki, Yoshihiko Funae, Hisashi Miyazaki and Susumu Imaoka and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition and Journal of Biochemical and Molecular Toxicology.

In The Last Decade

Masashi Mise

9 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masashi Mise Japan	6	296	127	84	73	60	9	372
Lucia F. Jorge-Nebert United States	9	276 0.9×	137 1.1×	65 0.8×	186 2.5×	51 0.8×	11	583
Yoshiaki Terauchi Japan	10	267 0.9×	135 1.1×	111 1.3×	95 1.3×	78 1.3×	20	428
Brian R. Baer United States	11	288 1.0×	138 1.1×	89 1.1×	171 2.3×	54 0.9×	17	459
M. Byron Kneller United States	7	295 1.0×	152 1.2×	74 0.9×	105 1.4×	67 1.1×	8	407
Kim J. Rich United Kingdom	13	281 0.9×	175 1.4×	40 0.5×	173 2.4×	58 1.0×	21	598
Jun Tatsuno Japan	6	327 1.1×	109 0.9×	52 0.6×	150 2.1×	36 0.6×	7	419
H. Yoshitsugu Japan	5	243 0.8×	161 1.3×	56 0.7×	141 1.9×	24 0.4×	6	518
Tsutomu Yoshimura Japan	13	171 0.6×	183 1.4×	48 0.6×	205 2.8×	73 1.2×	28	594
Katarina Stark Sweden	11	247 0.8×	83 0.7×	155 1.8×	151 2.1×	81 1.4×	12	421
Tom Rushmore United States	13	191 0.6×	126 1.0×	45 0.5×	193 2.6×	36 0.6×	14	485

Countries citing papers authored by Masashi Mise

Since Specialization

Citations

This map shows the geographic impact of Masashi Mise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Mise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Mise more than expected).

Fields of papers citing papers by Masashi Mise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Mise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Mise. The network helps show where Masashi Mise may publish in the future.

Co-authorship network of co-authors of Masashi Mise

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Mise. A scholar is included among the top collaborators of Masashi Mise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Mise. Masashi Mise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Usui, Toru, Masashi Mise, Takanori Hashizume, Masashi Yabuki, & Setsuko Komuro. (2009). Evaluation of the Potential for Drug-Induced Liver Injury Based on in Vitro Covalent Binding to Human Liver Proteins. Drug Metabolism and Disposition. 37(12). 2383–2392. 122 indexed citations

Mise, Masashi, Takanori Hashizume, & Setsuko Komuro. (2008). Characterization of Substrate Specificity of Dog CYP1A2 Using CYP1A2-Deficient and Wild-Type Dog Liver Microsomes. Drug Metabolism and Disposition. 36(9). 1903–1908. 22 indexed citations

Yamamoto, Midori, Masashi Mise, Sanae Matsumoto, et al.. (2004). Comparison of genomic and cDNA sequences of guinea pig CYP2B18 and rat CYP2B2: Absence of a phenobarbital‐responsive enhancer module in the upstream region of the CYP2B18 gene. Journal of Biochemical and Molecular Toxicology. 18(3). 124–130. 1 indexed citations

Mise, Masashi, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi, & Toshihiko Fujii. (2004). Identification of non-functional allelic variant of CYP1A2 in dogs. Pharmacogenetics. 14(11). 769–773. 31 indexed citations

Mise, Masashi, et al.. (2004). POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS. Drug Metabolism and Disposition. 32(2). 240–245. 32 indexed citations

Hashizume, Takanori, Susumu Imaoka, Masashi Mise, et al.. (2002). Involvement of CYP2J2 and CYP4F12 in the Metabolism of Ebastine in Human Intestinal Microsomes. Journal of Pharmacology and Experimental Therapeutics. 300(1). 298–304. 136 indexed citations

Hashizume, Takanori, Masashi Mise, Satoshi Matsumoto, et al.. (2001). A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.. PubMed. 29(6). 798–805. 21 indexed citations

Ito, Sadayoshi, et al.. (1995). [Studies on PCB toxicity involving 2C subfamily cytochrome P450].. PubMed. 86(5). 153–62. 3 indexed citations

Fujisaki, Hiroshi, Masashi Mise, Yuji Ishii, Hiroshi Yamada, & K. Oguri. (1994). Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.. Journal of Pharmacology and Experimental Therapeutics. 268(2). 1024–1031. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact